Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies

Expert Opinion on Drug Delivery

Volumn 6, Issue 3, 2009, Pages 255-270

  Velpandian, Thirumurthy ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Antibiotics; Antimicrobials; Bacterial keratitis; Endophthalmitis; Eye drops; Eye infections; Intraocular penetration; Ocular drug delivery

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN PHOSPHATE; DEXAMETHASONE; FLUCONAZOLE; GANCICLOVIR; GATIFLOXACIN; GENTAMICIN; HYALURONIC ACID; IMIPENEM; ITRACONAZOLE; LEVOFLOXACIN; LIPOSOME; LOMEFLOXACIN; MEROPENEM; MOXIFLOXACIN; NANOPARTICLE; NATAMYCIN; OFLOXACIN; OXACILLIN; SPARFLOXACIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN; DRUG CARRIER;

ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ASPERGILLOSIS; CLINICAL TRIAL; CONTINUOUS INFUSION; CORNEA ULCER; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG PENETRATION; DRUG RELEASE; DRUG STABILITY; ENDOPHTHALMITIS; EYE INFECTION; EYE INFLAMMATION; HUMAN; IONTOPHORESIS; KERATITIS; LENS IMPLANT; LOADING DRUG DOSE; MINIPUMP; MYCOSIS; NONHUMAN; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE; ANIMAL; CHEMISTRY; DRUG ADMINISTRATION; DRUG EFFECT; EYE; INJECTION; METABOLISM; MICROBIOLOGY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFECTIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG ADMINISTRATION SCHEDULE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOPHTHALMITIS; EYE; HUMANS; INJECTIONS;

EID: 66149144814     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425240902798119     Document Type: Review

References (108)

1. Lemley CA, Han DP. Endophthalmitis: a review of current evaluation and management. Retina 2007;27:662-680
2. Abreu JA, Alió JL, Cordovés LM, et al. The ESCRS study on antibiotic prophylaxis for endophthalmitis following cataract surgery. Arch Soc Esp Oftalmol 2006;81:627-630
3. Kamalarajah S, Ling R, Silvestri G, et al. Presumed infectious endophthalmitis following cataract surgery in the UK: a case-control study of risk factors. Eye 2007;21:580-586 (Pubitemid 46730703)
4. Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years' experience from a centre in India. Retina 2008;11
5. Vedantham V, Lalitha P, Velpandian T, et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Eye 2006;20:1273-1278 (Pubitemid 44698058)
6. Rajpal, Srinivas A, Azad RV, et al. Evaluation of vitreous levels of gatifloxacin after systemic administration in inflamed and non-inflamed eyes. Acta Ophthal Scan In press
7. Talwar D, Kulkarni A, Azad R, et al. Intraocular ciprofloxacin levels after oral administration in silicone oil-filled eyes. Invest Ophthalmol Vis Sci 2003;44:505-509 (Pubitemid 36159691)
8. Ravi AK, Biswas NR, Raju S, et al. Comparative evaluation of the ocular penetration of oral ofloxacin, pefloxacin, lomefloxacin and sparfloxacin in patients undergoing vitrectomy. Proceedings of Indian eye research group, IERG XVI July 28th 2007
9. Barza M, Kane A, Baum J. Oxacillin for bacterial endophthalmitis: subconjunctival, intravenous, both, or neither? Invest Ophthalmol Vis Sci 1980;19:1348-1354
10. Nossov PC, Alfaro DV, Michaud ME, et al. Intravenous cefazolin in penetrating eye injuries. A swine model. Retina 1996;16:246-249
11. Adenis JP, Mounier M, Salomon JL, et al. Human vitreous penetration of imipenem. Eur J Ophthalmol 1994;4:115-117 (Pubitemid 24248857)
12. Robert PY, Tassy A. Bioavailability of antibiotics. J Fr Ophtalmol 2000;23:510-513 (Pubitemid 30413247)
13. Kaushik S, Ram J, Brar GS, et al. Intracameral amphotericin B: initial experience in severe keratomycosis. Cornea 2001;20:715-719 (Pubitemid 34506469)
14. Barry P, Seal DV, Gettinby G, et al. ESCRS Endophthalmitis Study Group. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-410 (Pubitemid 44313820)
15. Barza M, Kane A, Baum JL. Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am J Ophthalmol 1977;83:407-413 (Pubitemid 8063272)
16. Kitagawa K, Fukuda M, Sasaki K. Intraocular penetration of topically administered acyclovir. Lens Eye Toxic Res 1989;6:365-373 (Pubitemid 19227081)
17. Oakley DE, Weeks RD, Ellis PP. Corneal distribution of subconjunctival antibiotics. Am J Ophthalmol 1976;81:307-312
18. Chapman JM, Abdelatif OM, Cheeks L, et al. Subconjunctival gentamicin induction of extraocular toxic muscle myopathy. Ophthalmic Res 1992;24:189-196
19. Barza M, Doft B, Lynch E. Ocular penetration of ceftriaxone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch Ophthalmol 1993;111:492-494 (Pubitemid 23116894)
20. Yu-Wai-Man P, Morgan SJ, Hildreth AJ, et al. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2008;34:447-451 (Pubitemid 351625595)
21. Liesegang TJ. Prophylactic antibiotics in cataract operations. Mayo Clin Proc 1997;72:149-159 (Pubitemid 28201647)
22. Kelkar A, Kelkar J, Amuaku W, et al. How to prevent endophthalmitis in cataract surgeries? Indian J Ophthalmol 2008;56:403-407
23. Fiscella R, Peyman GA, Fishman PH. Duration of therapeutic levels of intravitreally injected liposome-encapsulated clindamycin in the rabbit. Can J Ophthalmol 1987;22:307-309 (Pubitemid 17163898)
24. Gupta SK, Velpandian T, Dhingra N, et al. Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes. J Ocul Pharmacol Ther 2000a;16(6):511-518
25. Zeng S, Hu C, Wei H, et al. Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model. Ophthalmology 1993;100:1640-1644 (Pubitemid 23335927)
26. Kim EK, Kim HB. Pharmacokinetics of intravitreally injected liposome-encapsulated tobramycin in normal rabbits. Yonsei Med J 1990;31:308-314
27. Peyman GA, Charles HC, Liu KR, et al. Intravitreal liposome-encapsulated drugs: a preliminary human report. Int Ophthalmol 1988;12:175-182 (Pubitemid 19008936)
28. Assil KK, Frucht-Perry J, Ziegler E, et al. Tobramycin liposomes. Single subconjunctival therapy of pseudomonal keratitis. Invest Ophthalmol Vis Sci 1991;32:3216-3220
29. Liu KR, Peyman GA, Khoobehi B. Efficacy of liposome-bound amphotericin B for the treatment of experimental fungal endophthalmitis in rabbits. Invest Ophthalmol Vis Sci 1989;30:1527-1534 (Pubitemid 19185954)
30. Velpandian T, Narayanan K, Nag TC, et al. Retinal toxicity of intravitreally injected plain and liposome formulation of fluconazole in rabbit eye. Indian J Ophthalmol 2006;54:237-240 (Pubitemid 44747208)
31. Wiechens B, Grammer JB, Johannsen U, et al. Experimental intravitreal application of ciprofloxacin in rabbits. Ophthalmologica 1999;213:120-128 (Pubitemid 29049398)
32. Wiechens B, Neumann D, Grammer JB, et al. Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes. Int Ophthalmol 1998-1999;22:133-143
33. Rao VS, Peyman GA, Khoobehi B, et al. Evaluation of liposome-encapsulated clindamycin in Staphylococcus aureus endophthalmitis. Int Ophthalmol 1989;13:181-185 (Pubitemid 19201537)
34. Gupta SK, Dhingra N, Velpandian T, et al. Efficacy of fluconazole and liposome entrapped fluconazole for C. albicans induced experimental mycotic endophthalmitis in rabbit eyes. Acta Ophthalmol Scand 2000(b);78:448-450 (Pubitemid 30608652)
35. Moreira CA Jr, Armstrong DK, Jelliffe RW, et al. Sodium hyaluronate as a carrier for intravitreal gentamicin. An experimental study. Acta Ophthalmol (Copenh) 1991;69:45-49
36. Kleinmann G, Apple DJ, Chew J, et al. Hydrophilic acrylic intraocular lens as a drug-delivery system for fourth-generation fluoroquinolones. J Cataract Refract Surg 2006;32:1717-1721 (Pubitemid 44468009)
37. Michelson JB, Nozik RA. Experimental endophthalmitis treated with an implantable osmotic minipump. Arch Ophthalmol 1979;97:1345-1346 (Pubitemid 9247589)
38. Schaeffer HE, Krohn DL. Liposomes in topical drug delivery. Invest Ophthalmol Vis Sci 1982;22:220-227
39. Velpandian T, Gupta SK, Gupta YK, et al. Ocular drug targeting by liposomes and their corneal interactions. J Microencapsul 1999;16:243-250 (Pubitemid 29099605)
40. Velpandian T, Gupta SK, Gupta YK, et al. Enhanced permeability of liposome encapsulated ciprofloxacin on rabbit cornea. Proceedings of XII International conference of Eye Research held at Yokohama, Japan, 1996
41. Frucht-Perry J, Assil KK, Ziegler E, et al. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis. Cornea 1992;11:393-397
42. Cavalli R, Gasco MR, Chetoni P, et al. Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm 2002;238:241-245 (Pubitemid 34457892)
43. Losa C, Calvo P, Castro E, et al. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 1991;43:548-552
44. Bloomfield SE, Miyata T, Dunn MW, et al. Soluble gentamicin ophthalmic inserts as a drug delivery system. Arch Ophthalmol 1978;96:885-887 (Pubitemid 8314569)
45. Ivanova LA, Koroleva VG, Kontridze VS. Pharmacokinetic study of collagen-based intraocular films and caps of gentamycin sulfate. Farmatsiia 1979;28:31-34 (Pubitemid 9207537)
46. Grusha OV, Ivanova LA, Popova ZS, et al. Experimental study of intraocular collagen-based medicated films with dexamethasone and kanamycin. Vestn Oftalmol 1984;5:51-53 (Pubitemid 14022469)
47. Dorigo MT, De Natale R, Miglioli PA. Collagen shields delivery of netilmicin: a study of ocular pharmacokinetics. Chemotherapy 1995;41:1-4 (Pubitemid 24375186)
48. Phinney RB, Schwartz SD, Lee DA, et al. Collagen-shield delivery of gentamicin and vancomycin. Arch Ophthalmol 1988;106:1599-1604 (Pubitemid 18277807)
49. Assil KK, Zarnegar SR, Fouraker BD, et al. Efficacy of tobramycin-soaked collagen shields vs tobramycin eyedrop loading dose for sustained treatment of experimental Pseudomonas aeruginosa-induced keratitis in rabbits. Am J Ophthalmol 1992;113:418-423
50. Pleyer U, Legmann A, Mondino BJ, et al. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicans-induced keratomycosis in rabbits. Am J Ophthalmol 1992;113:303-308
51. Robin JB, Keys CL, Kaminski LA, et al. The effect of collagen shields on rabbit corneal reepithelialization after chemical debridement. Invest Ophthalmol Vis Sci 1990;31:1294-1300 (Pubitemid 20212359)
52. Hobden JA, Reidy JJ, O'Callaghan RJ, et al. Quinolones in collagen shields to treat aminoglycoside-resistant pseudomonal keratitis. Invest Ophthalmol Vis Sci 1990;31:2241-2243
53. Baziuk N, Gremillion CM Jr, Peyman GA, et al. Collagen shields and intraocular drug delivery: concentration of gentamicin in the aqueous and vitreous of a rabbit eye after lensectomy and vitrectomy. Int Ophthalmol 1992;16:101-107
54. Wang JM, Chu RY, Li YT. Cephradine delivery into the eye with domestic collagen shield. Zhonghua Yan Ke Za Zhi 1994;30:131-133
55. Liang FQ, Viola RS, del Cerro M, et al. Non-cross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbits eyes. Invest Ophthalmol Vis Sci 1992;33:2194-2198
56. Kuwano M, Horibe Y, Kawashima Y. Effect of collagen cross-linking in collagen corneal shields on ocular drug delivery. J Ocul Pharmacol Ther 1997;13:31-40 (Pubitemid 27130720)
57. Hosaka S, Ozawa H, Tanzawa H, et al. In vivo evaluation of ocular inserts of hydrogel impregnated with antibiotics for trachoma therapy. Biomaterials 1983;4:243-248
58. Silbiger J, Stern GA. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Ophthalmology 1992;99:889-892
59. Aquavella JV, Ruffini JJ, LoCascio JA. Use of collagen shields as a surgical adjunct. J Cataract Refract Surg 1988;14:492-495 (Pubitemid 18233600)
60. Renard G, Bennani N, Lutaj P, et al. Comparative study of a collagen corneal shield and a subconjunctival injection at the end of cataract surgery. J Cataract Refract Surg 1993;19:48-51 (Pubitemid 23230171)
61. Menchini U, Lanzetta P, Ferrari E, et al. Efficacy of collagen shields after extracapsular cataract extraction. Eur J Ophthalmol 1994;4:175-180 (Pubitemid 24324573)
62. Mendicute J, Ondarra A, Eder F, et al. The use of collagen shields impregnated with amphotericin B to treat Aspergillus keratomycosis. CLAO J 1995;21:252-255
63. Taravella M, Stepp P, Young D. Collagen shield delivery of tobramycin to the human eye. CLAO J 1998;24:166-168 (Pubitemid 28355244)
64. Taravella MJ, Balentine J, Young DA, et al. Collagen shield delivery of ofloxacin to the human eye. J Cataract Refract Surg 1999;25:562-565 (Pubitemid 29173471)
65. Hariprasad SM, Shah GK, Chi J, Prince RA. Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. J Cataract Refract Surg 2005;31:2142-2146 (Pubitemid 43075382)
66. Haugen B, Werner L, Romaniv N, et al. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis. J Cataract Refract Surg 2008;34:853-858 (Pubitemid 351615502)
67. Praus R, Brettschneider I, Krejcã L, Kalvodovã¡ D. Hydrophilic contact lenses as a new therapeutic approach for the topical use of chloramphenicol and tetracycline. Ophthalmologica 1972;165:62-70
68. Robin JS, Ellis PP. Ophthalmic ointments. Surv Ophthalmol 1978;22:335-340 (Pubitemid 8318534)
69. Matoba AY, McCulley JP. The effect of therapeutic soft contact lenses on antibiotic delivery to the cornea. Ophthalmology 1985;92:97-99 (Pubitemid 15170420)
70. Rootman DS, Willoughby RP, Bindlish R, et al. Continuous flow contact lens delivery of gentamicin to rabbit cornea and aqueous humor. J Ocul Pharmacol 1992;8:317-323 (Pubitemid 23040167)
71. Jain MR. Drug delivery through soft contact lenses. Br J Ophthalmol 1988;72:150-154 (Pubitemid 18063715)
72. Busin M, Spitznas M. Sustained gentamicin release by presoaked medicated bandage contact lenses. Ophthalmology 1988;95:796-798 (Pubitemid 18158493)
73. Tian X, Iwatsu M, Kanai A. Disposable 1-day Acuvue contact lenses for the delivery of lomefloxacin to rabbits' eyes. CLAO J 2001(a);27:212-215 (Pubitemid 33032816)
74. Tian X, Iwatsu M, Sado K, et al. Studies on the uptake and release of fluoroquinolones by disposable contact lenses. CLAO J 2001(b);27:216-220 (Pubitemid 33032817)
75. Hehl EM, Beck R, Luthard K, et al. Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses. Eur J Clin Pharmacol 1999;55:317-323 (Pubitemid 29290925)
76. Kutskaia IP, Golubev VN, Koroleva VG, et al. Prolonged-action gentamycin sulfate eyedrops. Antibiotiki 1981;26:60-64
77. Lehr CM, Lee YH, Lee VH. Improved ocular penetration of gentamicin by mucoadhesive polymer polycarbophil in the pigmented rabbit. Invest Ophthalmol Vis Sci 1994;35:2809-2814 (Pubitemid 24149794)
78. Ghelardi E, Tavanti A, Celandroni F, et al. Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits. J Antimicrob Chemother 2000;46:831-834 (Pubitemid 30843660)
79. Ghelardi E, Tavanti A, Davini P, et al. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis. Antimicrob Agents Chemother 2004;48:3396-3401 (Pubitemid 39129336)
80. Gurtler F, Kaltsatos V, Boisramã B, et al. Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert. Pharm Res 1995;12:1791-1795 (Pubitemid 26004703)
81. Mundada AS, Shrikhande BK. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm 2006;32:443-448
82. Felt O, Baeyens V, Buri P, et al. Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle. AAPS PharmSci 2001;3:E34 (Pubitemid 35450664)
83. Di Colo G, Zambito Y, Burgalassi S, et al. Effect of chitosan on in vitro release and ocular delivery of ofloxacin from erodible inserts based on poly(ethylene oxide). Int J Pharm 2002;248:115-122 (Pubitemid 35341415)
84. Kaiser RR, Rãckert PR. Hydrogel, a new galenic form in ophthalmology. Klin Monatsbl Augenheilkd 1990;196:405-406
85. Gandolfi SA, Massari A, Orsoni JG. Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers. Graefes Arch Clin Exp Ophthalmol 1992;230:20-23
86. Hobden JA, Rootman DS, O'Callaghan RJ, et al. Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas. Antimicrob Agents Chemother 1988;32:978-981 (Pubitemid 18177929)
87. Hobden JA, O'Callaghan RJ, Hill JM, et al. Tobramycin iontophoresis into corneas infected with drug-resistant Pseudomonas aeruginosa. Curr Eye Res 1989;8:1163-1169 (Pubitemid 20002325)
88. Grossman RE, Chu DF, Lee DA. Regional ocular gentamicin levels after transcorneal and transscleral iontophoresis. Invest Ophthalmol Vis Sci 1990;31:909-916 (Pubitemid 20186102)
89. Frucht-Pery J, Mechoulam H, Siganos CS, et al. Iontophoresis-gentamicin delivery into the rabbit cornea, using a hydrogel delivery probe. Exp Eye Res 2004;78:745-749 (Pubitemid 38183353)
90. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 2001;73:205-211 (Pubitemid 32539249)
91. Sultana Y, Aqil M, Ali A. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv 2006;13:215-219
92. Hardberger RE, Hanna C, Goodart R. Effects of drug vehicles on ocular uptake of tetracycline. Am J Ophthalmol 1975;80:133-138
93. George FJ, Hanna C. Ocular penetration of chloramphenicol. Effects of route of administration. Arch Ophthalmol 1977;95:879-882
94. O'Connor J, Lynch M, Vitale S, et al. Characteristics of effective village treatment assistants: the Kongwa Trachoma Project. Ophthalmic Epidemiol 1999;6:257-265
95. Ong-Tone L. Use of a wick to deliver preoperative mydriatics for cataract surgery. J Cataract Refract Surg 2003;29:2060-2062 (Pubitemid 37548746)
96. Ong-Tone L. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery. J Cataract Refract Surg 2008;34:819-822 (Pubitemid 351626964)
97. Cunha-Vaz JG. The blood-retinal barriers. Doc Ophthalmol 1976;41:287
98. Rizzolo LJ. Development and role of tight junctions in the retinal pigment epithelium. Int Rev Cytol 2007;258:195-234 (Pubitemid 46330486)
99. Hosoya K, Tomi M. Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol Pharm Bull 2005;28:1-8 (Pubitemid 40879774)
100. Senthilkumari S, Velpandian T, Biswas NR, et al. Evidencing the modulation of P-glycoprotein at blood-ocular barriers using Gamma Scintigraphy. Curr Eye Res 2009;34:73-77
101. Dey S, Gunda S, Mitra AK. Pharmacokinetics of erythromycin in rabbit corneas after single-dose infusion: role of P-glycoprotein as a barrier to in vivo ocular drug absorption. J Pharmacol Exp Ther 2004;311:246-255 (Pubitemid 39287804)
102. Kansara V, Hao Y, Mitra AK. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina. J Ocul Pharmacol Ther 2007;23:321-334 (Pubitemid 350195056)
103. Azema J, Guidetti B, Malet-Martino M, et al. Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs. Bioorg Med Chem 2006;14:2569-2580 (Pubitemid 43343644)
104. Banker AS. Posterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol 2008;56(5):377-383
105. Srivastava SK, Martin DF, Mellow SD, et al. Pathological findings in eyes with the ganciclovir implant. Ophthalmology 2005;112(5):780-786 (Pubitemid 40631496)
106. Cadman J. Ganciclovir implants: one year later. GMHC Treat Issues 1997;11(4/5):3-6
107. Chang M, Dunn JP. Ganciclovir implant in the treatment of cytomegalovirus retinitis. Expert Rev Med Devices 2005;2(4):421-427 (Pubitemid 41015124)
108. Yasukawa T, Ogura Y, Kimura H, et al. Drug delivery from ocular implants. Expert Opin Drug Deliv 2006;3(2):261-273 (Pubitemid 43338096)